The effect of stress on the pharmacokinetics and pharmacodynamics of glibenclamide in diabetic rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 3, 1998, Pages 371-376

  Abd Elaziz, M A ^a   Al Dhawailie, A A ^a   Tekle, A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Glibenclamide; Pharmacodynamics; Pharmacokinetics; Stress

Indexed keywords

EUGLYCON; GLIBENCLAMIDE; GLUCOSE; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROVOCATION TEST; RAT; STRESS;

EID: 0031772511     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03192296     Document Type: Article

References (24)

1. Kovar M.G., Harris M.I., Madden W. (1987) : The scope of diabetes in the United States population. Am. J. Public Health, 77, 1549-1550.
2. Pohl S.L., Gonder-Frederick L.A., Cox D.G. (1994) : Diabetes mellitus: an overview. Behav. Med. Update, 6, 3-7.
3. Richard S.S., Mark S.S., Mark N.F. (1992) : Stress and diabetes mellitus. Diabetes Care, 15, 1413-1422.
4. Guillemin R. (1978) : Hypothalamus, hormones and physiological regulation. In: Debbs-Robin E. (Ed.) Claude Bernard and the internal environment. A memorial symposium. New York: Dekker, 137-156.
5. Motoo Y., Yutaka G., Ryozo Oishi. (1991) : Influence of foot shock stress on pharmacokinetics of microrandil in rats. Life Sci., 48, 2065-2073.
6. Mikat E.M., HacKel D.B., Cruz P.T., Lebovit Z.H.E. (1972) : Lower glucose tolerance in the sand rat (Psammonys obesus) resulting from esophageal intubation. Proc. Soc. Exp. Biol. Med., 139, 1390-1391.
7. Jaber L.A., Lewis N.J., Slaughter R.L., Neole A.V. (1993) : The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy. J. Clin. Pharmacol., 33, 239-245.
8. Turner N.C., White P. (1996) : Effects of streptozotocin-induced diabetes on vascular reactivity in genetically hyperinsulinaemic obese Zucker rats. J. Cardiovasc. Pharmacol., 27, 884-890
9. Tekle A., Al-Khamis I. (1990) : Phenytoin bupropion interaction: effect on plasma phenytoin concentration in the rat. J. Pharm. Pharmacol., 42, 799-801.
10. Gamallo A., Alario P., Gonzalez Abad M.J., Villanua M.A. (1992) : Acute noise stress, ACTH administration, and blood pressure alteration. Physiol. Behav., 51, 1201-1205.
11. Al-Dhawailie A.A., Abdulaziz M.A., Tekle A., Matar K.M. (1995) : A simple specific and rapid high performance liquid Chromatographic assay for glibenclamide in plasma. J. Liquid Chromatogr., 18, 3981-3990.
12. Clutter W.E., Bier D.M., Shah S.D., Cryer P.E. (1980) : Epinephrine plasma metabolic clearance rate, and physiologic thresholds for metabolic and hemodynamic actions in man. J. Clin. Invest., 66, 74-101.
13. Williams R.H., Porte D. (1974) : The pancreas. In: Williams R.H. (Ed.) Textbook of Endocrinology, 5th edn. Philadelphia, PA: Saunders, 502-526.
14. Landsberg L., Young J.B. (1985) : Sympathoadrenal system: the regulation of metabolism. In: Ingbar S.H. (Ed.) Contemporary endocrinology, vol. 2. New York: Plenum, 217-246.
15. Leahy J.L. (1990) : Natural history of B-cell dysfunction in NIDDM. Diabetes Care, 13, 992-1010.
16. Unger R.H., Grundy S. (1985) : Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia, 28, 119-121.
17. Surwit R.S., Feinglos M.N. (1988) : Stress and autonomic nervous system in type II diabetes, a hypothesis, Diabetes Care, 11, 83-85.
18. Surwit R.S., Feinglos M.N., Livingston E.G., Kuhn C.M., McCubbin J.A. (1984) : Behavioral manipulation of the diabetic phenotype in ob/ob mice. Diabetes, 33, 616-618.
19. Melesky C.H., Lewis S.B., Woodruff R.E. (1973) : Glucogon level during anesthesia and surgery in normal diabetic patients [Abstract]. Diabetes, 27, 492.
20. Robertson P.R., Halter J.B., Porte D. (1976) : A role of alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J. Clin. Invest., 57, 791-795.
21. Kashiwagi A., Harano Y., Suzuki M. et al. (1986) : New alpha2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients. Diabetes, 35, 1085-1089.
22. Naliboff B.D., Cohen M.J., Sowers J.D. (1985) : Physiological and metabolic responses to brief stress in non-insulin dependent diabetic and control subjects. J. Psychosom. Res., 29, 367-374.
23. Armario A., Martio O., Gaualda A. (1992) : Negative feedback of corticosterone on the pituitary-adrenal axis is maintained after inhibition of serotonin synthesis with parachlorophenylalanine. Brain Res. Bull., 28, 915-918.
24. Brechi M.C., Scatizzi R., Martinotti E., Pellegrini A., Soldani P., Paparelli A. (1994) : Morphofunctional changes in the non-adrenergic innervation of the rat cardiovascular system after varying duration of noise stress. Int. J. Neurosci., 75, 73-81.